Constellium SE
NYSE:CSTMAluminum
+$0.32 today
- Market cap
- $2.88B
- Beta
- 1.54
- P/E (TTM)
- 10.7
- EPS (TTM)
- $3.17
Volume 1.46M
Average 2.27M
CSTM Net Income
Bottom-line profit, the starting point for calculating cash from operations.
Constellium SENYSE: CSTM
Net Income · Q3 FY2026 · quarter ended Sep 2026
Net income grows 35.2% year over year
Q3 FY2026 net income of $119M rose 35.2% year over year. Sequentially, it fell 19.6% from the prior quarter. Over 3 fiscal years it compounded at -4.8% a year.
Context
- Net income amounted to 3.2% of revenue in FY2025, up 2.5 pp from a year earlier.
- Net income increased in 1 of the last 3 fiscal years.
What to watch
Whether net income reaches the consensus estimate from 4 analysts of $536.84M (+96.7%) for the fiscal year ending Dec 2026, a slowdown from the +404.7% reported in FY2025.
Sources:Cash Flow Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterSep 2026
- $119M-19.6% QoQ
- Last fiscal yearDec 2025
- $272.92M+404.7% YoY
- LTMSep 2026
- $574.97M— YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | +35.2% | -35.5% | -70.7 pp |
| 1 year | +404.7% | +96.7% | -308.0 pp |
| 3-year CAGR | -4.8% | +11.9% | +16.7 pp |
| 5-year CAGR | — | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
Net Income history
Mixed currencies · from the cash flow
- Latest · FY2025
- 272.92M USD
- Year-over-year change
- —
| Period | Period end | Net Income | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 272.92M | — |
| FY2024 | 2024-12-31 | 54.08M | -64.4% |
| FY2023 | 2023-12-31 | 152M | -52.0% |
| FY2022 | 2022-12-31 | 316.34M | +6.6% |
| FY2021 | 2021-12-31 | 296.64M | — |
Net Income vs competitors
How CSTM compares with its peers on the latest reported figures
- Peers report in different currencies, so net income is compared through growth and share of revenue rather than absolute size.
- Net income amounts to 5.7% of revenue for CSTM, versus a peer median of 17.5%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| FY2026 | ZAR 4.09B ZAR | +82.5% | +47.3% | 38.1% | |
| LTM Mar 2026 | R$1.75B BRL | +49.7% | — | 3.9% | |
| LTM Sep 2026 | $885.9M USD | +1210.5% | — | 29.6% | |
| LTM Jun 2026 | $683M USD | -18.4% | — | 37.1% | |
| LTM Sep 2026 | $574.97M USD | — | -4.8% | 5.7% | |
| LTM Jun 2026 | $395.02M USD | +125.8% | — | 33.4% | |
| LTM Jun 2026 | $311.75M USD | +116.3% | +37.6% | 29.8% | |
| LTM Jun 2026 | $227M USD | +316.5% | — | 5.5% | |
| LTM Jun 2026 | $138.1M USD | +757.8% | — | 2.1% | |
| LTM Sep 2026 | $120.31M USD | -37.7% | -46.3% | 1.8% | |
| LTM Jul 2026 | $90.12M USD | +453.5% | -4.5% | 4.3% | |
| Peer median (excluding CSTM) | — | +121.1% | +16.5% | 17.5% | |
Competitors are the stored peer set for CSTM. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 · EUR | FY2022 Dec 2022 · EUR | FY2023 Dec 2023 · EUR | FY2024 Dec 2024 · EUR | FY2025 Dec 2025 · USD |
|---|---|---|---|---|---|
| Net Income | 296.64M | 316.34M | 152M | 54.08M | 272.92M |
| Depreciation & Amortization | 302.3M | 287M | 275.07M | 293.57M | 330M |
| Deferred Income Tax | 55M | (133.47M) | 75M | 72.43M | 0 |
| Stock-Based Compensation | 15M | 0 | 0 | 0 | 0 |
| Change in Working Capital | (261M) | (90.38M) | (119M) | (181.55M) | (222.93M) |
| Accounts Receivables | (227M) | 162.9M | (37M) | (48.29M) | (202.94M) |
| Inventory | (435M) | (253.28M) | 202M | (23.18M) | (148.95M) |
| Accounts Payables | 396M | 43.09M | (206M) | (38.63M) | 167.95M |
| Other Working Capital | 5M | (43.09M) | (78M) | (71.46M) | (38.99M) |
| Other Non-Cash Items | (50.94M) | 93.45M | 48.93M | 52.15M | 108.87M |
| Operating Cash Flow | 357M | 472.94M | 432M | 290.68M | 488.85M |
| Capital Expenditures | (232M) | (286.92M) | (366M) | (398.83M) | (329.9M) |
| Acquisitions (Net) | 9.36M | 2.1M | 49M | 9.66M | 11M |
| Purchases of Investments | 0 | 0 | 0 | 0 | 0 |
| Sales of Investments | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activities | 1.64M | (1.05M) | 98M | 82.08M | 3M |
| Investing Cash Flow | (221M) | (285.87M) | (219M) | (307.09M) | (315.9M) |
| Debt Repayment | (377M) | (126.12M) | (166M) | 13.52M | (60.98M) |
| Common Stock Issued | 0 | 0 | 0 | 0 | 0 |
| Common Stock Repurchased | 0 | 0 | 0 | (76.29M) | (114.96M) |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | (58M) | (42.04M) | (8M) | 8.69M | (31.99M) |
| Financing Cash Flow | (435M) | (168.16M) | (174M) | (54.08M) | (207.94M) |
| Effect of Forex Changes | 7M | (8.92M) | 6.84M | (8.69M) | 14M |
| Net Change in Cash | (292M) | 10M | 45.84M | (79.19M) | (20.99M) |
| Free Cash Flow | 125M | 186.02M | 66M | (108.16M) | 158.95M |
Constellium SE
NYSE:CSTM
Intrinsic Alpha fair value
Locked
Current Price
$21.37
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.